Carman Alenson
Comptroller/Controller/Auditor at PRIME MEDICINE, INC.
Net worth: - $ as of 31/05/2024
Carman Alenson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 01/08/2021 | - |
| Director of Finance/CFO | 01/08/2021 | 17/01/2024 |
Career history of Carman Alenson
Former positions of Carman Alenson
| Companies | Position | Start | End |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 07/11/2016 | 30/07/2021 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2015 | 01/10/2016 |
Training of Carman Alenson
| Boston University | Masters Business Admin |
Statistics
International
| United States | 4 |
| Israel | 2 |
Operational
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Carman Alenson
- Experience
